A Vaccine against Ebola Virus

Cell. 2020 Apr 2;181(1):6. doi: 10.1016/j.cell.2020.03.011.

Abstract

Ervebo is the first licensed vaccine for prevention of Ebola virus disease. The vaccine, originally developed by the Public Health Agency of Canada, is delivered in a single 1 mL dose and has been delivered to >200,000 people in an ongoing 2018-2020 outbreak of disease. To view this Bench to Bedside, open or download the PDF.

MeSH terms

  • Antibodies, Viral / immunology*
  • Disease Outbreaks / prevention & control*
  • Drug Approval
  • Ebola Vaccines / immunology*
  • Ebolavirus
  • Hemorrhagic Fever, Ebola / prevention & control*
  • Humans
  • Mass Vaccination*
  • Viral Envelope Proteins / immunology

Substances

  • Antibodies, Viral
  • Ebola Vaccines
  • Viral Envelope Proteins
  • envelope glycoprotein, Ebola virus